Akari Therapeutics PLC (AKTX)

1.48 +0.02 (+1.37%) USD  |  NASDAQ  |  May 16, 16:00
1.46 -0.02 (-1.35%) After-Hours: 20:00
More

Akari Therapeutics Quarterly Revenue Estimates

Quarterly Revenue Estimates Chart

View Quarterly Revenue Estimates for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Quarterly Revenue Estimates Data

View and export this data back to 2022. Upgrade now.
Date Value
December 31, 2022 --
Date Value
September 30, 2022 --

Quarterly Revenue Estimates Range, Past 5 Years

--
Minimum
Sep 2022
--
Maximum
Sep 2022
--
Average
--
Median
Sep 2022

Quarterly Revenue Estimates Benchmarks

DBV Technologies SA Upgrade
Cellectis SA Upgrade
Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals Plc --
NuCana PLC Upgrade